The Middle East is turning heads in the biotech world. What used to be a region known for oil is now becoming a global player in health innovation and sustainability. And Paul Sterriker, an experienced venture capitalist and entrepreneur, sees a golden opportunity.
“This isn’t just about catching up; it’s about leading,” Paul says, leaning into his decades of experience across healthcare and innovation.
Here’s the thing about biotech in the Middle East—it’s not just about fancy labs and cutting-edge tools. It’s about solving real problems. Paul explains it well: “When you’ve got unique challenges—like a higher prevalence of genetic disorders or limited water resources—you start seeing really creative solutions.”
Take healthcare, for example. Startups in the region are developing AI-powered tools that diagnose diseases faster and more accurately. “They’re not reinventing the wheel; they’re making the wheel work better for this part of the world,” Paul points out.
Agriculture is another big one. With climate change affecting how the region grows food, biotech startups are working on crops that need less water or meat grown in labs. “It’s not just innovation for innovation’s sake,” Paul says. “These ideas are grounded in what people here need.”
Even governments are throwing serious weight on biotech. Saudi Arabia has its National Biotechnology Strategy aiming to make the country a global leader by 2030. The UAE is building research hubs and investing in education to grow local talent.
“This isn’t just government spending for the sake of PR,” Paul says. “It’s about creating ecosystems that actually attract talent and investment.”
And the market is responding. Venture capital in the biotech sector has exploded. In 2024, over 50 funds were actively investing in biotech startups across the region. “When you have money flowing and ideas blooming, you get momentum. That’s where we are now,” Paul adds.
Of course, no landscape is without its challenges. Paul Sterriker acknowledges the hurdles—limited networks, the need for more localized research, and scaling issues. But he’s optimistic. “The foundations are being laid right now. Governments are investing, the talent pool is growing, and the ecosystem is maturing,” he says.
Paul sees mentorship as a critical piece of the puzzle. “Startups need more than money—they need guidance. That’s where I come in. It’s about helping them navigate challenges, refine their ideas, and connect with the right people,” he explains.
Paul’s interest in biotech isn’t just business—it’s personal. With a deep commitment to sustainability, he’s invested in ventures that align profit with purpose. “We can’t afford to ignore the impact of our choices,” he says. Whether it’s supporting green tech startups or backing companies developing drought-resistant crops, Paul believes biotech is uniquely positioned to make a difference.
So, whether you’re an entrepreneur with a bold idea or an investor looking to make an impact, there’s no better time to dive in and become a part of the biotech revolution of the MENA region. And with people like Paul Sterriker leading the way, the Middle East is proving it’s ready to take on the challenge.